Valby, Denmark

Karen Eichstedt Sørensen


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karen Eichstedt Sørensen: Innovator in Pharmaceutical Formulations

Introduction

Karen Eichstedt Sørensen is a notable inventor based in Valby, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that address critical health issues. Her work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving patient outcomes.

Latest Patents

Karen holds a patent for a pharmaceutical formulation comprising a 2-[(2-pyridinyl)methyl] sulfinyl benzimidazole, which has demonstrated anti-ulcer activity. This patent details an oral pharmaceutical formulation that includes granules with an inert core, coated with a layer containing the active ingredient, a disintegrant, and a surfactant. The formulation utilizes a melt coating technique, which enhances the delivery and effectiveness of the benzimidazole compound.

Career Highlights

Throughout her career, Karen has been associated with A/S Gea Farmaceutisk Fabrik, where she has played a pivotal role in advancing pharmaceutical research and development. Her innovative approach has led to the creation of effective treatments that benefit patients suffering from ulcer-related conditions.

Collaborations

Karen has collaborated with esteemed colleagues such as Kristian Lund Henriksen and Helle Kann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.

Conclusion

Karen Eichstedt Sørensen's contributions to pharmaceutical formulations highlight her role as a leading inventor in the industry. Her innovative work continues to pave the way for advancements in healthcare, demonstrating the importance of research and collaboration in developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…